- Enabling a New Level of Ion Mobility Intelligence
IonDX provides next-generation ion mobility technology to analyze biologic drugs from glycoproteins and CRISPR-Cas to mRNA and lipid nanoparticles
February 8, 2023Ion Mobility,Latest news,Journal publication,Cryo-EM sample prepFebruary 7, 2023Soft landing,Cryo-EM sample prep,Ion MobilityFebruary 7, 2023Ion Mobility,Structural info,Gene TherapyMore Posts IMgenius
Accelerating the next generation of biologic drugs
Versatile
Applies to a wide range of biologics
Soft ionization conditions allow native conformations of biomacromolecules to be studied, e.g., non-covalent protein complexes, high molecular weight aggregates, mRNA, glycoproteins, CRISPR-Cas, virus particles, lipid nanoparticles
Benchtop
Fits easily into your lab
IonDX’s patented ion mobility technology provides powerful analytical characterization in a very compact benchtop design.
Ion Mobility
Operates at atmospheric pressure
IMgenius determines the mobility of a population of molecular ions as they travel through a gas under the influence of an electric field. Small ions have higher mobility than larger ions because they experience less drag as they travel through a gas.
About Us
Our Mission
We're Hiring!
Resources
Tutorials
Brand Assets
Contact Us
info@iondx.com